GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FullHope Biomedical Co Ltd (ROCO:7773) » Definitions » Current Deferred Revenue

FullHope Biomedical Co (ROCO:7773) Current Deferred Revenue : NT$0.00 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FullHope Biomedical Co Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

FullHope Biomedical Co's current deferred revenue for the quarter that ended in Jun. 2024 was NT$0.00 Mil.

FullHope Biomedical Co Current Deferred Revenue Historical Data

The historical data trend for FullHope Biomedical Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FullHope Biomedical Co Current Deferred Revenue Chart

FullHope Biomedical Co Annual Data
Trend Dec21 Dec22 Dec23
Current Deferred Revenue
- - -

FullHope Biomedical Co Quarterly Data
Dec22 Jun23 Dec23 Jun24
Current Deferred Revenue - - - -

FullHope Biomedical Co Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of FullHope Biomedical Co's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


FullHope Biomedical Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Lane 609, Sector. 5, Chongxin Road, 10th Floor, No. 10, Sanchong District, New Taipei City, TWN
FullHope Biomedical Co Ltd focuses on immune system-related services and innovative R&D. It establishes cell-based immunotherapies for cancers and autoimmune disorders. Its services are, Immunoprofiling, Circulating Tumor Cells Testing, Regulation of Cell Therapy, Contracting Immune Cell Manufacturing, Immune Cell Bank, Contract Research Organization, and Endotoxin and Mycoplasma Detection Service.

FullHope Biomedical Co Headlines

No Headlines